Kenyataan Media Pengarah NPRA 24 Mac 2022 - Status Laporan Kesan Advers Susulan Imunisasi (AEFI) Vaksin COVID-19 Sehingga 18 Mac 2022
- Posted By Amir Imran Abdul Rahaman
- Jumlah paparan: 63873
Kadar pengguna: 5 / 5
 |
 |
 |
 |
National Pharmaceutical Regulatory Agency (NPRA)
Lot 36, Jalan Universiti (Jalan Prof Diraja Ungku Aziz), 46200 Petaling Jaya, Selangor, Malaysia.
- Phone: +603-7883 5400
More Links
More Links
DISCLAIMER
The Government of Malaysia and the National Pharmaceutical Regulatory Agency are not responsible for any loss or damage caused by the usage of any information obtained from this website.
Site Last Modified
- Last Modified: Selasa 03 Disember 2024, 10:01:04.